20 March 2024 in Clinical Kidney Journal
Primary membranous nephropathy (pMN) is one of the most common types of glomerulonephritis, with a third of patients progressing to renal insufficiency. Various prognostic factors have been reported, of which urinary protein and renal function are the most critical parameters. Fractional excretion of total protein (FETP) indicates protein leakage that accounts for creatinine kinetics and serum protein levels. In this study, we investigated the association between FETP and renal prognosis in pMN. We retrospectively identified 150 patients with pMN. FETP was calculated as follows: (serum creatinine × urine protein)/(serum protein × urine creatinine) %. We divided the patients into three groups according to FETP values and compared the clinicopathological findings. The primary outcome was an estimated glomerular filtration rate (eGFR) decrease of ≥30% from the baseline level. FETP was associated with urinary protein and renal function, Ehrenreich and Churg stage, and global glomerulosclerosis. The primary outcome was observed in 38 patients (25.3%), and the frequency of the primary outcome was higher in the high FETP group (P = .001). FETP is higher than protein–creatinine ratio (PCR) in the area under the curve. In the multivariate analysis adjusted for age, eGFR, PCR and treatment, FETP was significantly associated with primary outcome (adjusted hazard ratio, 8.19; P = .019). FETP is a valuable indicator that can reflect the pathophysiology and is more useful than PCR as a predictor of renal prognosis in patients with Japanese pMN.
23 January 2020 in CEN Case Reports
The immunoglobulin (Ig) D type is a rare variant of multiple myeloma (MM), that accounts for 1–2% of all cases. Compared to the more common types of MM, IgD MM is known to have more severe symptoms at presentation, and a poorer prognosis. A woman was admitted to our hospital for severe acute kidney disease and disorder (AKD) and back pain, and was started on hemodialysis. The renal biopsy revealed light chain cast nephropathy. She was diagnosed with IgD-λ MM based on Bence-Jones protein expression and high IgD serum levels, and started bortezomib therapy with plasma exchange (PE). After three sessions of PE, the serum free light chain levels decreased by 92%, and she was withdrawn from dialysis. The patient underwent autologous transplantation and is still in remission, demonstrating the benefits of a bortezomib-based regimen in combination with PE for IgD MM with AKD.
7 July 2025 in Clinical Kidney Journal
Background: Sodium–glucose co-transporter 2 inhibitors (SGLT2i) reduce glomerular hyperfiltration, resulting in an initial estimated glomerular filtration rate (eGFR) dip in chronic kidney disease (CKD). The association between the initial eGFR dip after SGLT2i and proteinuria reduction has not been explored. Fractional excretion of total protein (FETP) is an index of protein leakage corrected for GFR and may be useful in addressing this issue. Methods: FETP was calculated as (serum creatinine × urine protein)/(serum protein × urine creatinine) (in %) and the initial FETP dip was defined as 3 months/baseline FETP. The patients were divided into three groups according to the initial FETP dip tertile: FETP acute dipper, moderate dipper and riser. The association between initial FETP dip after SGLT2i and the eGFR slope over the subsequent 2 years was retrospectively investigated. Results: The study involved 238 patients, including 105 with diabetes mellitus. The patients’ median age was 57.0 years and eGFR was 43.0 ml/min/1.73 m2. The initial FETP dip was associated with the baseline eGFR, protein:creatinine ratio and FETP. The eGFR slope in the FETP acute dipper was −0.2 ml/min/1.73 m2/year, which was less than those of the moderate dipper and riser (−1.0 and −1.3 ml/min/1.73 m2/year; P < .001). Multivariate regression analyses revealed that the initial FETP dip was associated with the eGFR slope independent of potential confounders (P < .001). Conclusions: An FETP acute dip after SGLT2i is associated with a favourable renal prognosis in CKD, indicating that FETP is a useful index for assessing the efficacy of SGLT2i.